Marker Therapeutics, Inc.

Daily Archives: Wednesday, December 12, 2018

Marker Therapeutics Exits ASH An Optimist. Should That Be Enough For You?

Marker Therapeutics has emerged out of a merger with Tapimmune to push forward new cell-based cancer vaccines.

Read More